1. Home
  2. LUNA vs CTSO Comparison

LUNA vs CTSO Comparison

Compare LUNA & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUNA
  • CTSO
  • Stock Information
  • Founded
  • LUNA 1990
  • CTSO 1997
  • Country
  • LUNA United States
  • CTSO United States
  • Employees
  • LUNA N/A
  • CTSO N/A
  • Industry
  • LUNA Biotechnology: Commercial Physical & Biological Resarch
  • CTSO Medical/Dental Instruments
  • Sector
  • LUNA Health Care
  • CTSO Health Care
  • Exchange
  • LUNA Nasdaq
  • CTSO Nasdaq
  • Market Cap
  • LUNA 67.3M
  • CTSO 57.2M
  • IPO Year
  • LUNA 2006
  • CTSO N/A
  • Fundamental
  • Price
  • LUNA $1.63
  • CTSO $0.90
  • Analyst Decision
  • LUNA Strong Buy
  • CTSO Strong Buy
  • Analyst Count
  • LUNA 1
  • CTSO 3
  • Target Price
  • LUNA $8.00
  • CTSO $4.67
  • AVG Volume (30 Days)
  • LUNA 159.9K
  • CTSO 155.7K
  • Earning Date
  • LUNA 11-22-2024
  • CTSO 11-07-2024
  • Dividend Yield
  • LUNA N/A
  • CTSO N/A
  • EPS Growth
  • LUNA N/A
  • CTSO N/A
  • EPS
  • LUNA N/A
  • CTSO N/A
  • Revenue
  • LUNA $116,614,000.00
  • CTSO $37,739,531.00
  • Revenue This Year
  • LUNA $13.35
  • CTSO $13.09
  • Revenue Next Year
  • LUNA $11.96
  • CTSO $15.68
  • P/E Ratio
  • LUNA N/A
  • CTSO N/A
  • Revenue Growth
  • LUNA 14.31
  • CTSO 1.80
  • 52 Week Low
  • LUNA $1.43
  • CTSO $0.70
  • 52 Week High
  • LUNA $7.92
  • CTSO $2.15
  • Technical
  • Relative Strength Index (RSI)
  • LUNA 44.55
  • CTSO 42.35
  • Support Level
  • LUNA $1.55
  • CTSO $0.71
  • Resistance Level
  • LUNA $1.80
  • CTSO $0.99
  • Average True Range (ATR)
  • LUNA 0.14
  • CTSO 0.10
  • MACD
  • LUNA 0.02
  • CTSO 0.01
  • Stochastic Oscillator
  • LUNA 50.00
  • CTSO 51.39

About LUNA Luna Innovations Incorporated

Luna Innovations Inc is engaged in optical technology, providing high-performance fiber optic test, measurement, and control products for the telecommunications, and photonics industries, and distributed fiber optic sensing solutions that measure and monitor materials and structures for applications in aerospace, automotive, oil, and gas, security, and infrastructure. Its Lightwave segment develops, manufactures, and markets optical measurements technologies like Sensing including short, medium, and long-range distributed fiber optic sensing solutions and Terahertz measurement products, and Communications test and photonic control including test equipment for communications devices and networks and specialty laser and photonic components. It derives a majority of its revenue from the U.S.

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales, Distributors/strategic partners, and Government segments. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

Share on Social Networks: